Intangible Assets, net

12 Months Ended

Dec. 29, 2020

Intangible Assets, net

Intangible Assets, net

8.    Intangible Assets, net

The following table presents components of intangible assets, net (in thousands):

	December 29, 2020		December 31, 2019
Indefinite-lived intangible assets:
Goodwill	$	1,451	$	78,355
Trade names and trademarks		233,676		337,027
Transferable alcoholic beverage licenses		7,753		8,575
Total indefinite-lived intangible assets		242,880		423,957
Definite-lived intangible assets, net:
Licensing agreements		7,320		10,060
Non-transferable alcoholic beverage licenses		2,960		3,190
Total definite-lived intangible assets		10,280		13,250
Total intangible assets, net	$	253,160	$	437,207

Amortization expenses related to our definite-lived intangible assets were $0.7 million, $0.3 million and $0.6 million for fiscal 2020, 2019 and 2018, respectively. Definite-lived intangible assets will be amortized over one to 55 years.

Due to the decrease in our stock price coupled with the dining room closures related to the COVID-19 pandemic and significant decline to the equity value of our peers and overall U.S. stock market, we determined it was necessary to perform an interim assessment of our goodwill, trade names, trademarks and licensing agreements during the first quarter of fiscal 2020. For the goodwill impairment test, the estimated fair value of the reporting units was determined using a blend of the income approach using a discounted cash flow analysis and the market capitalization approach. The fair value of the trade names, trademarks and licensing agreements was estimated using the relief from royalty method. There were a number of estimates and significant judgments made by management in performing these evaluations, such as future unit growth, average unit volumes, cash flows, discount rates and royalty rates. Accordingly, actual results could vary significantly from such estimates.

Based on the results of this assessment, we recorded goodwill impairment expense related to the Other FRC, North Italia and Flower Child operating segments of $33.8 million, $27.7 million and $17.9 million, respectively. In addition, we recorded impairment expense of $101.0 million and $2.3 million related to trade names and trademarks, and licensing agreements, respectively. More than half of the total impairment amount was driven by the impact on our market capitalization, with the balance related to lower future cash flow estimates. The reduced projections stemmed primarily from our decision to delay fiscal 2020 unit development, thereby moving our expected unit growth trajectory out by one year. The cash flow estimates assumed that average unit volumes and margins would substantially return to pre-COVID-19 levels by mid-fiscal 2021. We performed our annual assessment of indefinite-lived intangible assets as of the first day of our fiscal fourth quarter and concluded as of the date of the test that there was no further impairment of these assets, other than $0.4 million of expense related to transferable alcoholic beverage licenses.